Published in Can Med Assoc J on May 20, 1978
Relative hyperactivity of brain centres. Can Med Assoc J (1978) 0.75
Depression of growth in hyperactive children on stimulant drugs. N Engl J Med (1972) 1.50
Growth rebound after termination of stimulant drugs. J Pediatr (1975) 1.06
The effects of methylphenidate (Ritalin) on the motor skills and behavior of children with learning problems. J Nerv Ment Dis (1969) 0.98
Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics (1973) 0.97
Hyperactives as young adults: preliminary report. Can Med Assoc J (1976) 0.94
Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison. Arch Gen Psychiatry (1974) 0.89
Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children. Am J Psychiatry (1972) 0.87
Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. Pediatrics (1976) 0.87
The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action. Psychopharmacologia (1975) 0.84
STUDIES ON THE HYPERACTIVE CHILD. I: SOME PRELIMINARY FINDINGS. Can Psychiatr Assoc J (1964) 0.84
Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction. Psychopharmacologia (1972) 0.83
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol (1999) 10.86
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol (1992) 3.00
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry (2001) 2.74
Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet (1999) 2.68
Great ape DNA sequences reveal a reduced diversity and an expansion in humans. Nat Genet (2001) 2.62
Pattern of nucleotide substitution and rate heterogeneity in the hypervariable regions I and II of human mtDNA. Genetics (1999) 2.42
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36
mtDNA sequence diversity in Africa. Am J Hum Genet (1996) 2.28
Melanesian origin of Polynesian Y chromosomes. Curr Biol (2000) 2.27
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 2.20
Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry (1985) 2.17
Iron, anaemia, and inflammatory bowel diseases. Gut (2004) 2.03
The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol (2001) 1.91
Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol (2000) 1.81
Effect of long-term treatment of hyperactive children with methylphenidate. Can Med Assoc J (1975) 1.78
Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol (2000) 1.76
Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry (2001) 1.76
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology (2001) 1.68
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry (2001) 1.63
Independent histories of human Y chromosomes from Melanesia and Australia. Am J Hum Genet (2000) 1.58
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry (1996) 1.58
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors. J Clin Oncol (1999) 1.56
Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens (2008) 1.54
Assessing menstrual cycles with urinary hormone assays. Am J Physiol Endocrinol Metab (2002) 1.46
Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study. Cancer J Sci Am (1997) 1.45
The hyper-IgE syndrome. Two cases and review of the literature. Int J Dermatol (2001) 1.44
A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium. Ann Oncol (1996) 1.43
The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci (1992) 1.42
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut (2002) 1.41
The marital and family functioning of adults with ADHD and their spouses. J Atten Disord (2004) 1.40
H CLASSES OF HOLOMORPHIC FUNCTIONS IN TUBE DOMAINS. Proc Natl Acad Sci U S A (1964) 1.38
Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol (1993) 1.36
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry (1997) 1.35
Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem (1993) 1.35
Familial aggregation of ADHD characteristics. J Abnorm Child Psychol (2000) 1.32
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion. J Clin Oncol (1993) 1.32
Solubilization and reconstitution of the membrane-bound carotenogenic enzymes from daffodil chromoplasts. Eur J Biochem (1985) 1.31
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry (2001) 1.29
Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol (2000) 1.28
Neural networks as a tool for utilizing laboratory information: comparison with linear discriminant analysis and with classification and regression trees. Proc Natl Acad Sci U S A (1991) 1.27
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry (2001) 1.25
Estimating the age of the common ancestor of men from the ZFY intron. Science (1996) 1.23
Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J Immunol (1999) 1.21
Parenchymal sparing surgery in patients with hereditary renal cell carcinoma. J Urol (1995) 1.21
Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol Cell Biol (1996) 1.20
Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J Infect Dis (2001) 1.19
[Gas chromatographic examinations of sebaceous gland lipids. I. Total lipid determination]. Arch Klin Exp Dermatol (1970) 1.18
NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry (1995) 1.18
Young adult outcome of hyperactive children who received long-term stimulant treatment. J Am Acad Child Psychiatry (1984) 1.16
Comparison of the effects of chlorpromazine, dextroamphetamine and methylphenidate on the behaviour and intellectual functioning of hyperactive children. Can Med Assoc J (1971) 1.14
Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta (1999) 1.14
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group. J Clin Oncol (1993) 1.12
Severe anaemia in Zambian children with Plasmodium falciparum malaria. Trop Med Int Health (2000) 1.08
Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol (1997) 1.08
Ralstonia pickettii-innocent bystander or a potential threat? Clin Microbiol Infect (2006) 1.08
Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab (2008) 1.07
Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem (2001) 1.07
Utilisation of locally delivered doxycycline in non-surgical treatment of chronic periodontitis. A comparative multi-centre trial of 2 treatment approaches. J Clin Periodontol (2001) 1.07
Size-selective preparation of inorganic fibers for biological experiments. Am Ind Hyg Assoc J (1979) 1.07
Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol (2002) 1.05
Prolonged macrophage activation and persistent anaemia in children with complicated malaria. Trop Med Int Health (1998) 1.05
Imported malaria: six cases of severe Plasmodium falciparum infection in Innsbruck, Austria, within a period of five weeks (February/March 1999) Wien Klin Wochenschr (2000) 1.05
The hyperactive child in elementary school: a 5 year, controlled, followup. Except Child (1971) 1.05
A 5-year follow-up study of 91 hyperactive school children. J Am Acad Child Psychiatry (1972) 1.04
Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology (2001) 1.04
Studies on the hyperactive child. 8. Five-year follow-up. Arch Gen Psychiatry (1971) 1.03
Tryptophan degradation to control T-cell responsiveness. Immunol Today (2000) 1.03
Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokines. Med Oncol (2001) 1.03
A scanning microscope study of the topography of HeLa cells. Cancer Res (1974) 1.03
Hyperactives as young adults: a controlled prospective ten-year follow-up of 75 children. Arch Gen Psychiatry (1979) 1.01
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days. Anticancer Drugs (1992) 1.01
Attention in hyperactive children and the effect of methylphenidate (ritalin). J Child Psychol Psychiatry (1971) 1.01
Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection. Curr Drug Metab (2007) 1.01
Lectin target cells in human central nervous system and the pituitary gland. Histochemistry (1984) 1.01
Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans. Gastroenterology (1984) 1.00
Effects of the Aspergillus fumigatus siderophore systems on the regulation of macrophage immune effector pathways and iron homeostasis. Immunobiology (2008) 1.00
ADHD in parents. J Am Acad Child Adolesc Psychiatry (2000) 0.99
IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int Immunol (2000) 0.99
Controlled micromanipulation of human sperm in three dimensions with an infrared laser optical trap: effect on sperm velocity. Fertil Steril (1992) 0.99
Nitric oxide and the post-transcriptional control of cellular iron traffic. Trends Cell Biol (1994) 0.99
Studies on the hyperactive child. V. The effects of dextroamphetamine and chlorpromazine on behaviour and intellectual functioning. J Child Psychol Psychiatry (1968) 0.99
Ca2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Biochem J (1993) 0.98
Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet (1991) 0.98
A peptide prodrug approach for improving bisphosphonate oral absorption. J Med Chem (2000) 0.98
Quality of life and immune activation in patients with HIV-infection. Brain Behav Immun (2008) 0.97
Intracerebral radio stimulation and recording in completely free patients. J Nerv Ment Dis (1968) 0.97
Interleukin-2-based therapy for metastatic renal cell cancer: the Cytokine Working Group experience, 1989-1997. Cancer J Sci Am (1997) 0.97
Subcellular distribution of a factor inactivating tyrosine aminotransferase. Study of its mechanism and relationship to different forms of the enzyme. Eur J Biochem (1978) 0.96
Hearing and middle ear function in osteogenesis imperfecta. JAMA (1982) 0.96
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers. Pharmacol Res (2009) 0.96
Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol (1993) 0.95